Dr George Hruby

Clinical Associate Professor
Medicine, Central Clinical School

Telephone 02 95158057
Fax 02 95158115

Map

Selected grants

2008

  • Preop chemoradiotherapy&postop chemo with capeciabine&oxaliplatin vs capecitabine alone in locally a; Price T, Harvey J, Tebbutt N, Hruby G, Bydder S, Simes R, Zalcberg J; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Broadbent, A., Hruby, G. (2008). Brain secondaries. In N. Christakis and P. Glare (Eds.), Prognosis in Advanced Cancer, (pp. 285-294). Oxford: Oxford University Press.

Journals

  • Thompson, J., Hruby, G. (2014). The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails. Annals of Surgical Oncology, 21(5), 1517-1519. [More Information]
  • Gzell, C., Kench, J., Stockler, M., Hruby, G. (2013). Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature. International Urology and Nephrology, 45(3), 735-742. [More Information]
  • Finnigan, R., Hruby, G., Wratten, C., Keller, J., Tripcony, L., Dickie, G., Rischin, D., Poulsen, M. (2013). The Impact of Preradiation Residual Disease Volume on Time to Locoregional Failure in Cutaneous Merkel Cell Carcinoma-A TROG Substudy. International Journal of Radiation Oncology, Biology, Physics, 86(1), 91-95. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]
  • Martin, D., Hruby, G., Whitaker, M., Foo, K. (2012). Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. Journal of Medical Imaging and Radiation Oncology, 56(6), 703-707. [More Information]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]
  • Whalley, D., Patanjali, N., Jackson, M., Lovett, A., Chatfield, M., Hruby, G. (2012). HDR brachytherapy combined with external beam radiation for localised prostate cancer: Early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology, 56(2), 220-226. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Goldstein, D., Spry, N., Cummins, M., Brown, C., van Hazel, G., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S., Wratten, C., Hruby, G., Horvath, L., Gebski, V., et al (2012). The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British Journal of Cancer, 106(1), 61-69. [More Information]
  • Gee, H., Hruby, G. (2012). Update on the management of merkel cell carcinoma. Cancer Forum, 36(3), 1-5.
  • Gee, H., Hruby, G. (2012). Update on the Management of Merkel Cell Carcinoma. Cancer Forum, 36(3), 1-5.
  • Suchowerska, N., Jackson, M., Lambert, J., Yin, Y., Hruby, G., McKenzie, D. (2011). Clinical Trials of a Urethral Dose Measurement System in Brachytherapy Using Scintillation Detectors. International Journal of Radiation: Oncology - Biology - Physics, 79(2), 609-615. [More Information]
  • Chen, J., Hruby, G., Stockler, M., Patanjali, N., Bucci, J., Perez, G., Loadsman, J., Sheehan, E. (2011). Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study. Brachytherapy, 10(6), 454-460. [More Information]
  • Hruby, G., Chen, J., Bucci, J., Loadsman, J., Perry, P., Stockler, M. (2011). Patients' experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocol. Brachytherapy, 10(5), 395-400. [More Information]
  • Whitaker, M., Hruby, G., Lovett, A., Patanjali, N. (2011). Prostate HDR brachytherapy catheter displacement between planning and treatment delivery. Radiotherapy and Oncology, 101(3), 490-494. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]
  • Zajac, J., Solomon, M., Hruby, G., Frizelle, F. (2009). Review of 120 anal cancer patients. Colorectal Disease: The official journal of the Association of Coloproctology of Great Britain and Ireland, 11, 909-14. [More Information]
  • Doyle, C., Loadsman, J., Hruby, G. (2008). An audit of analgesia requirements for high-dose-rate prostate brachytherapy. Anaesthesia and Intensive Care, 36(5), 707-709. [More Information]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Harrison, J., Solomon, M., Young, J., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S. (2008). Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. JAMA (formerly Archives Of Surgery), 143(4), 389-394. [More Information]
  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Harrison, J., Solomon, M., Young, J., Meagher, A., Hruby, G., Salkeld, G., Clarke, S. (2007). Surgical and oncology trials for rectal cancer: Who will participate? Surgery, 142(1), 94-101. [More Information]
  • Broadbent, A., Hruby, G., Tin, M., Jackson, M., Firth, I. (2004). Survival Following Whole Brain Radiation Treatment For Cerebral Metastases: An Audit Of 474 Patients. Radiotherapy and Oncology, 71(3), 259-265.

2014

  • Thompson, J., Hruby, G. (2014). The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails. Annals of Surgical Oncology, 21(5), 1517-1519. [More Information]

2013

  • Gzell, C., Kench, J., Stockler, M., Hruby, G. (2013). Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature. International Urology and Nephrology, 45(3), 735-742. [More Information]
  • Finnigan, R., Hruby, G., Wratten, C., Keller, J., Tripcony, L., Dickie, G., Rischin, D., Poulsen, M. (2013). The Impact of Preradiation Residual Disease Volume on Time to Locoregional Failure in Cutaneous Merkel Cell Carcinoma-A TROG Substudy. International Journal of Radiation Oncology, Biology, Physics, 86(1), 91-95. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]

2012

  • Martin, D., Hruby, G., Whitaker, M., Foo, K. (2012). Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. Journal of Medical Imaging and Radiation Oncology, 56(6), 703-707. [More Information]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]
  • Whalley, D., Patanjali, N., Jackson, M., Lovett, A., Chatfield, M., Hruby, G. (2012). HDR brachytherapy combined with external beam radiation for localised prostate cancer: Early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology, 56(2), 220-226. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Goldstein, D., Spry, N., Cummins, M., Brown, C., van Hazel, G., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S., Wratten, C., Hruby, G., Horvath, L., Gebski, V., et al (2012). The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British Journal of Cancer, 106(1), 61-69. [More Information]
  • Gee, H., Hruby, G. (2012). Update on the management of merkel cell carcinoma. Cancer Forum, 36(3), 1-5.
  • Gee, H., Hruby, G. (2012). Update on the Management of Merkel Cell Carcinoma. Cancer Forum, 36(3), 1-5.

2011

  • Suchowerska, N., Jackson, M., Lambert, J., Yin, Y., Hruby, G., McKenzie, D. (2011). Clinical Trials of a Urethral Dose Measurement System in Brachytherapy Using Scintillation Detectors. International Journal of Radiation: Oncology - Biology - Physics, 79(2), 609-615. [More Information]
  • Chen, J., Hruby, G., Stockler, M., Patanjali, N., Bucci, J., Perez, G., Loadsman, J., Sheehan, E. (2011). Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study. Brachytherapy, 10(6), 454-460. [More Information]
  • Hruby, G., Chen, J., Bucci, J., Loadsman, J., Perry, P., Stockler, M. (2011). Patients' experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocol. Brachytherapy, 10(5), 395-400. [More Information]
  • Whitaker, M., Hruby, G., Lovett, A., Patanjali, N. (2011). Prostate HDR brachytherapy catheter displacement between planning and treatment delivery. Radiotherapy and Oncology, 101(3), 490-494. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]

2009

  • Zajac, J., Solomon, M., Hruby, G., Frizelle, F. (2009). Review of 120 anal cancer patients. Colorectal Disease: The official journal of the Association of Coloproctology of Great Britain and Ireland, 11, 909-14. [More Information]

2008

  • Doyle, C., Loadsman, J., Hruby, G. (2008). An audit of analgesia requirements for high-dose-rate prostate brachytherapy. Anaesthesia and Intensive Care, 36(5), 707-709. [More Information]
  • Broadbent, A., Hruby, G. (2008). Brain secondaries. In N. Christakis and P. Glare (Eds.), Prognosis in Advanced Cancer, (pp. 285-294). Oxford: Oxford University Press.
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Harrison, J., Solomon, M., Young, J., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S. (2008). Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. JAMA (formerly Archives Of Surgery), 143(4), 389-394. [More Information]

2007

  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Harrison, J., Solomon, M., Young, J., Meagher, A., Hruby, G., Salkeld, G., Clarke, S. (2007). Surgical and oncology trials for rectal cancer: Who will participate? Surgery, 142(1), 94-101. [More Information]

2004

  • Broadbent, A., Hruby, G., Tin, M., Jackson, M., Firth, I. (2004). Survival Following Whole Brain Radiation Treatment For Cerebral Metastases: An Audit Of 474 Patients. Radiotherapy and Oncology, 71(3), 259-265.

To update your profile click here. For support on your academic profile contact .